适应症
干预措施
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- Bayer
- 入组人数
- 2,725
- 主要终点
- Patient distribution per indication
研究概览
简要总结
Mirena is used for long-term in Kazakhstan, and in our observational program we would like to study patients distribution per indications of Mirena, and also patient compliance within a year after Mirena insertion. For patients with all approved indications for Mirena use: contraception, treatment of menorrhagia and protection from endometrial hyperplasia during estrogen replacement therapy
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- Female
- 接受健康志愿者
- 否
入选标准
- •Patients older than 18 years with previously taken decision of their gynecologist to insert Mirena according to registered indications
排除标准
- •All patients with contraindications to Mirena insertion, according to approved prescribing information.
研究组 & 干预措施
Group 1
干预措施: Levonorgestrel (Mirena, BAY86-5028) (Drug)
结局指标
主要结局
Patient distribution per indication
时间窗: 12 months
次要结局
- Patient compliance(12 months)
研究者
相似试验
已完成
不适用
Mirena Post-marketing Surveillance in JapanContraceptionNCT01414140Bayer567
已完成
不适用
Data on the Impact of Different Treatment on the Quality of Life of Patients With Acute and Chronic Hemorrhoid DiseaseHemorrhoidsNCT03743311Servier Russia1,032
已完成
不适用
Mirena or Conventional Medical Treatment for MenorrhagiaMenorrhagiaNCT00864136Bayer647
已完成
不适用
MiCo - Mirena or Conventional Medical Treatment for MenorrhagiaIdiopathic MenorrhagiaNCT01085487Bayer1,211
已完成
不适用
MIRENA for Contraception In InDian Subjects User continuAtion and Satisfaction Study: MIDAS StudyContraceptionNCT01961375Bayer600